LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 13.87 | 27.76 | 269 | 604 | 0.4448 | 0.6668 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 13.87 | 27.76 | 961 | 604 | 1.5892 | 1.2197 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 15.58 | 27.76 | 205 | 685 | 0.2990 | 0.5406 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 15.58 | 27.76 | 921 | 685 | 1.3434 | 1.1318 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 15.58 | 27.76 | 460 | 685 | 0.6710 | 0.8347 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 15.58 | 27.76 | 1015 | 685 | 1.4805 | 1.1770 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 17.28 | 27.76 | 390 | 838 | 0.4650 | 0.7116 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 17.28 | 27.76 | 921 | 838 | 1.0981 | 1.0384 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 17.28 | 27.76 | 758 | 838 | 0.9038 | 0.9593 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 17.28 | 27.76 | 1015 | 838 | 1.2102 | 1.0791 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.98 | 27.76 | 546 | 941 | 0.5802 | 0.7969 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.98 | 27.76 | 955 | 941 | 1.0147 | 1.0058 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.98 | 27.76 | 865 | 941 | 0.9191 | 0.9671 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.98 | 27.76 | 1050 | 941 | 1.1157 | 1.0435 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 20.68 | 27.76 | 683 | 1119 | 0.6104 | 0.8232 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 20.68 | 27.76 | 972 | 1119 | 0.8686 | 0.9479 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 20.68 | 27.76 | 895 | 1119 | 0.7998 | 0.9180 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 20.68 | 27.76 | 1057 | 1119 | 0.9446 | 0.9787 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 22.39 | 27.76 | 879 | 1305 | 0.6732 | 0.8625 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 22.39 | 27.76 | 1002 | 1305 | 0.7674 | 0.9069 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 22.39 | 27.76 | 962 | 1305 | 0.7368 | 0.8930 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 22.39 | 27.76 | 1090 | 1305 | 0.8348 | 0.9360 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 24.09 | 27.76 | 876 | 1461 | 0.5993 | 0.8287 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 24.09 | 27.76 | 1016 | 1461 | 0.6951 | 0.8768 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 24.09 | 27.76 | 1037 | 1461 | 0.7095 | 0.8835 | MN20160318_Q01 | G04 |